头盔使用与头盔法规降低成年摩托车骑手死亡率和颈椎损伤的系统综述与Meta分析:东部创伤外科协会实践管理指南
本指南由东部创伤外科协会制定,采用PICO框架和GRADE方法,系统检索多个数据库,纳入28项研究回答骑手是否佩戴头盔(PICO 1)、10项研究回答是否实施通用头盔法规(PICO 2)。头盔使用与较低死亡率(OR 0.48,95%CI 0.41-0.56,p<0.001)和较低颈椎损伤发生率(OR 0.66,95%CI 0.58-0.76,p<0.001)相关。PICO 2因方法学异质性大未能进行Meta分析,但绝大多数研究显示通用头盔法规带来大幅结局改善。因偏倚风险,PICO 1和PICO 2的总体证据确定性均评为低。指南强烈推荐个人骑手佩戴头盔并颁布执行通用头盔法规。
要点
- 头盔使用与死亡率降低相关:OR 0.48(95%CI 0.41-0.56,p<0.001),证据确定性低。
- 头盔使用与颈椎损伤发生率降低相关:OR 0.66(95%CI 0.58-0.76,p<0.001),证据确定性低。
- 通用头盔法规因方法学异质性未能Meta分析,但绝大多数研究显示结局大幅改善。
- 东部创伤外科协会强烈推荐成年摩托车骑手佩戴头盔,并强烈推荐颁布和执行通用头盔法规。
- 推荐目的为降低死亡率、降低颈椎损伤发生率和改善出院去向。
适用人群与场景
- 成年摩托车骑手(PICO 1比较佩戴与不佩戴头盔,PICO 2比较实施与不实施通用头盔法规)。
研究设计与关键结果
- 系统综述与Meta分析共纳入28项研究分析PICO 1(头盔使用),10项研究分析PICO 2(通用头盔法规)。
- 头盔使用与较低死亡率相关:OR 0.48(95%CI 0.41-0.56,p<0.001)。
- 头盔使用与较低颈椎损伤发生率相关:OR 0.66(95%CI 0.58-0.76,p<0.001)。
- PICO 2因显著方法学异质性未能进行Meta分析,但绝大多数研究显示通用头盔法规带来结局大幅改善。
- PICO 1和PICO 2的总体证据确定性均因偏倚风险评为低。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析,证据等级Level III。
- 采用GRADE方法评估证据质量和制定推荐,工作组对最终循证推荐达成共识。
- 研究注册于PROSPERO(CRD42020172705)。
- 局限:PICO 1和PICO 2的总体证据确定性均因偏倚风险评为低;PICO 2因显著方法学异质性未能进行Meta分析。
对床旁实践的改变
- 东部创伤外科协会强烈推荐成年摩托车骑手佩戴头盔,以降低死亡率、降低颈椎损伤发生率和改善出院去向。
- 东部创伤外科协会强烈推荐颁布和执行通用头盔法规,以降低死亡率、降低颈椎损伤发生率和改善出院去向。
指南或共识出处
- 东部创伤外科协会(Eastern Association for the Surgery of Trauma)实践管理指南:头盔使用与头盔法规降低成年摩托车骑手死亡率和颈椎损伤的系统综述与Meta分析。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Motorcycle crash fatalities remain a significant public health concern. Traumatic brain injury is a leading cause of death following motorcycle crash. We aim to provide evidence-based guidelines pertaining to helmet use and helmet laws with respect to important outcomes including mortality, cervical spine injury, and discharge disposition.
METHODS: An evidence-based systematic review was performed to answer the following Population, Intervention, Comparator, Outcomes (PICO) questions: PICO 1-Should adult motorcycle riders wear helmets or not wear helmets to improve mortality, brain injury-related mortality, cervical spine injury, and discharge disposition from the hospital? PICO 2-Should motorcycle universal helmet laws (UHLs) or no UHLs be enacted to improve mortality, brain injury-related mortality, cervical spine injury, and discharge disposition from the hospital? An academic medical librarian searched Medline, Cochrane CENTRAL, CINAHL, Embase, Engineering Village, Health and Safety Science Abstracts, Scopus, SPORTDiscus, TRID, the VHL Regional Portal, and Elsevier. The Grading of Recommendations Assessment, Development, and Evaluation methodology was used to assess the quality of the evidence and create recommendations. The working group reached consensus on the final evidence-based recommendations. The study was registered in PROSPERO (CRD42020172705).
RESULTS: A total of 28 studies were identified for analysis for PICO 1, and 10 studies were identified for PICO 2. Helmet use was associated with a lower incidence of mortality (odds ratio, 0.48; 95% confidence interval, 0.41-0.56; p < 0.001) and lower incidence of cervical spine injury (odds ratio, 0.66; 95% confidence interval, 0.58-0.76; p < 0.001). Although a meta-analysis for PICO 2 was not possible because of significant methodological heterogeneity, the vast majority of studies demonstrated large improvements in outcomes with a UHL. Overall certainty of evidence was deemed low for PICO 1 and PICO 2 because of risk of bias.
CONCLUSION: We strongly recommend that individual motorcycle riders wear helmets and that universal helmet legislation be enacted and enforced to decrease mortality, to decrease the incidence of cervical spine injury, and to improve discharge disposition from the hospital.
LEVEL OF EVIDENCE: Systematic Review and Meta-analysis; Level III.
参考来源
- Ratnasekera AM, Seng SS, Gardiner SK, et al. Systematic review and meta-analysis of efficacy of helmet use and helmet laws to reduce mortality and cervical spine injury in adult motorcycle riders: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2025. PMID: 40462278. doi:10.1097/TA.0000000000004607
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。